HEMATO is an Exclusive, One-of-its-Kind Premium and Most Comprehensive vertical of Transcell Oncologics Pvt Ltd. It is a most comprehensive, non-clinical medical technology platform in offering the full SUITE of options for Hematopoietic Stem Cell Transplantation (HSCT) based on Peripheral Blood Stem Cell (PBSC), Umbilical Cord Blood (UCB), and Bone Marrow (BM).

HEMATO is being successfully used and recommended by leading Hemato Oncologists in major Hospitals/Chains and Clinics in the country, while HSCT is regularly practiced at CMC, Narayana Health, Apollo, Yashoda, Rainbow Children's Hospitals.

About S Dravida, CEO